Epidemic meningitis, meningococcaemia, and Neisseria meningitidis, Lancet, vol.369, pp.2196-210, 2007. ,
Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States, Ther Adv Vaccines, vol.5, pp.3-14, 2017. ,
Vaccines for the prevention of meningococcal capsular group B disease: what have we recently learned?, Hum Vaccin Immunother, vol.12, pp.235-243, 2016. ,
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens, Vaccine, vol.30, issue.2, pp.87-97, 2012. ,
Neisseria meningitidis group B correlates of protection and assay standardization-international meeting, Vaccine, vol.24, pp.5093-107, 2005. ,
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines, Proc Natl Acad Sci, vol.107, pp.19490-19495, 2010. ,
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?, Pathog Dis, vol.75, p.25, 2017. ,
MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine, Vaccine, vol.33, pp.2629-2665, 2015. ,
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines, Clin Vaccine Immunol, vol.19, pp.1609-1626, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02085510
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage, Vaccine, vol.31, pp.4968-74, 2013. ,
Pooled-sera hSBA titres predict individual seroprotection in infants and toddlers vaccinated with 4CMenB, Vaccine, vol.34, pp.2579-84, 2016. ,
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, pp.416-441, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02093031
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine, BMC Microbiol, vol.14, p.111, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00990250
High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland, Vaccine, vol.34, pp.510-515, 2016. ,
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal, PLoS One, vol.12, p.176177, 2017. ,
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB), Vaccine, vol.32, pp.124-154, 2013. ,
Predicted strain coverage of a new meningococcal multicomponent vaccine (4CMenB) in Spain: Analysis of the differences with other European countries, PLoS One, vol.11, p.150721, 2016. ,
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment, Lancet Infect Dis, vol.17, pp.754-62, 2017. ,
Antigen Typing System (MATS)-based Neisseria meningitidis serogroup B coverage prediction for the MenB-4C vaccine in the United States, vol.2, pp.261-317, 2017. ,
Predicted strain coverage of four-component meningococcal serogroup B vaccine (4CMenB) in Finland, Program and abstracts of the 20th international pathogenic Neisseria conference. Manchester, UK2016, p.279 ,
Enter B and W: two new meningococcal vaccine programmes launched, Arch Dis Child, vol.101, pp.91-96, 2016. ,
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study, Lancet, vol.388, pp.2775-82, 2016. ,
Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens, PLoS One, vol.9, p.89921, 2014. ,
Underestimation of invasive meningococcal disease in Italy, Emerg Infect Dis, vol.22, pp.469-75, 2016. ,
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine, Clin Vaccine Immunol, vol.17, pp.919-948, 2010. ,
R: A language and environment for statistical computing, 2013. ,
Agreement: Statistical tools for measuring agreement. R package version, pp.8-9, 2012. ,
Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine, Infect Immun, vol.81, pp.560-569, 2013. ,
Distribution of Bexsero Ò Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation, Vaccine, vol.34, pp.4690-4697, 2016. ,
Temporal changes in BEXSERO Ò antigen sequence type associated with genetic lineages of Neisseria meningitidis over a 15-year period in Western Australia, PLoS One, vol.11, p.158315, 2016. ,
Targeted DNA enrichment and whole genome sequencing of Neisseria meningitidis directly from clinical specimens, Int J Med Microbiol, vol.308, pp.256-62, 2018. ,
The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines, Vaccine, vol.30, issue.2, pp.73-80, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02085503
Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes, Sci Rep, vol.8, p.3700, 2018. ,
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C, Vaccine, vol.35, pp.4236-4280, 2017. ,
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine, Expert Rev Vaccines, vol.9, pp.1203-1220, 2010. ,
Development of Bexsero Ò outer membrane vesicle typing system for analysis of meningococcal whole genome sequences, p.17, 2017. ,
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined, Proc Natl Acad Sci U S A, vol.113, pp.2714-2723, 2016. ,
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines, PLoS One, vol.13, p.197186, 2018. ,
The challenge of post-implementation surveillance for novel meningococcal vaccines, Vaccine, vol.30, issue.2, pp.67-72, 2012. ,
BIGSdb: Scalable analysis of bacterial genome variation at the population level, BMC Bioinf, vol.11, p.595, 2010. ,